Nocturnal hypoventilation: Predictors and outcomes in childhood progressive neuromuscular disease

Archives of Disease in Childhood

Volumn 95, Issue 12, 2010, Pages 998-1003

  Katz, Sherri L ^a,b   Gaboury, Isabelle ^c   Keilty, Krista ^d,e   Banwell, Brenda ^d,e,f   Vajsar, Jiri ^d,f   Anderson, Peter ^a   Ni, Andy ^a,b   MacLusky, Ian ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DYSTROPHINOPATHY; FEMALE; HEALTH STATUS; HUMAN; HYPOVENTILATION; LABORATORY TEST; LUNG FUNCTION; MALE; MUSCLE STRENGTH; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NOCTURNAL HYPOVENTILATION; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TOTAL LUNG CAPACITY;

ADOLESCENT; CARBON DIOXIDE; CHILD; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPOVENTILATION; MALE; MUSCLE STRENGTH; NEUROMUSCULAR DISEASES; POLYSOMNOGRAPHY; PROGNOSIS; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SCOLIOSIS; VITAL CAPACITY;

EID: 78649901713     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.182709     Document Type: Article

References (37)

1. Katz SL. Assessment of sleep-disordered breathing in pediatric neuromuscular diseases. Pediatrics 2009;123(Suppl 4):S222-5.
2. Labanowski M, Schmidt-Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology 1996;47:1173-80. (Pubitemid 26374882)
3. Perrin C, Unterborn JN, Ambrosio CD, et al. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29:5-27. (Pubitemid 38040552)
4. Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000;161:166-70.
5. Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000;29:141-50. (Pubitemid 30060966)
6. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004;170:456-65.
7. Baydur A, Layne E, Aral H, et al. Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review. Thorax 2000;55:4-11.
8. Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000;118:1390-6.
9. Guilleminault C, Philip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatr 1998;65:225-32.
10. Simonds AK, Muntoni F, Heather S, et al. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998; 53:949-52.
11. Culebras A. Sleep disorders and neuromuscular disease. Semin Neurol 2005;25:33-8.
12. Shneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002;20:480-7.
13. Simonds AK. Ethical aspects of home long term ventilation in children with neuromuscular disease. Paediatr Respir Rev 2005;6:209-14.
14. Ward S, Chatwin M, Heather S, et al. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005;60:1019-24.
15. Baldassari CM, Mitchell RB, Schubert C, et al. Pediatric obstructive sleep apnea and quality of life: a meta-analysis. Otolaryngol Head Neck Surg 2008;138:265-73.
16. Chervin RD, Ruzicka DL, Giordani BJ, et al. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics 2006;117:e769-78.
17. Gozal D. S leep-disordered breathing and school performance in children. Pediatrics 1998;102:616-20.
18. Gibson ES, Powles AC, Thabane L, et al. "Sleepiness" is serious in adolescence: two surveys of 3235 Canadian students. BMC Public Health 2006;6:116.
19. O'Brien LM, Gozal D. Behavioural and neurocognitive implications of snoring and obstructive sleep apnoea in children: facts and theory. Paediatr Respir Rev 2002;3:3-9.
20. O'Brien LM, Holbrook CR, Mervis CB, et al. Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attentiondeficit/hyperactivity disorder. Pediatrics 2003;111:554-63.
21. Halbower AC, Mahone EM. Neuropsychological morbidity linked to childhood sleep-disordered breathing. Sleep Med Rev 2006;10:97-107.
22. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 1996;153:866-78.
23. American Thoracic Society. Cardiorespiratory sleep studies in children. Establishment of normative data and polysomnographic predictors of morbidity. Am J Respir Crit Care Med 1999;160:1381-7.
24. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
25. Lindsley C, Wright S, Pachman L, et al. Consensus and economic advantages of abbreviated manual muscle testing (MMT) in the assessment of idiopathic inflammatory myopathies (IIM). Arthritis Rheum 2001;44.
26. Legg AT, Merril JB.Physical therapy in infantile paralysis reprinted from principles and practice of physical therapy. Hagerstown, Maryland: WF Prior, 1932.
27. Landgraf JM, Abetz L, Ware JE.The CHQ: a user's manual. Boston, Massachusetts: The Health Institute, 1996.
28. Conners CK. Conners' Rating Scales-revised technical manual. Toronto: Multi-Health Systems, 1997.
29. Conners CK. A teacher rating scale for use in drug studies with children. Am J Psychiatry 1969;126:884-8.
30. Conners CK, Barkley RA. Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 1985;21:809-43.
31. Hennekens CH, Buring JE. Epidemiology in medicine. Boston, Massachusetts: Little, Brown and Company, 1987.
32. Ragette R, Mellies U, Schwake C, et al. P atterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002;57:724-8.
33. Dohna-Schwake C, Ragette R, Mellies U, et al. Respiratory function in congenital muscular dystrophy and limb girdle muscular dystrophy 2I. Neurology 2004;62:513-14.
34. Martin TJ, Sanders MH. Chronic alveolar hypoventilation: a review for the clinician. Sleep 1995;18:617-34.
35. Sawicka EH, Branthwaite MA. Respiration during sleep in kyphoscoliosis. Thorax 1987;42:801-8.
36. Nugent AM, Smith IE, Shneerson JM. Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 2002;121:459-64.
37. Iber C, Ancoli-Israel S, Chesson AL, et al. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Page 47. 1 edn. Westchester, Illinois: American Academy of Sleep Medicine, 2007.